CLINICAL_TRIALS
trial_result
· 2012-01-26
Clinical Trial Update: MOA Study of Ze 339 in Seasonal Allergic Rhinitis [Phase 2]
Summary
Phase 2 MOA study of Ze 339 for seasonal allergic rhinitis has completed; the update does not include study results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Max Zeller Soehne AG | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED